Arcadia Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1K Hold
18
﹤0.01% 208
2025
Q4
$12.2K Sell
18
-21
-54% -$14.3K ﹤0.01% 215
2025
Q3
$24.9K Hold
39
﹤0.01% 200
2025
Q2
$20.9K Sell
39
-195
-83% -$93.2K ﹤0.01% 205
2025
Q1
$98.3K Sell
234
-875
-79% -$380K 0.02% 158
2024
Q4
$459K Sell
1,109
-1,452
-57% -$637K 0.07% 93
2024
Q3
$1.29M Hold
2,561
0.21% 68
2024
Q2
$1.25M Buy
2,561
+1,998
+355% +$1M 0.21% 64
2024
Q1
$304K Buy
+563
New +$308K 0.05% 105

Other funds holding IDXX

Arcadia Investment Management's IDXX Position: Q1 2026 in Review

Arcadia Investment Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 18 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #208.

Arcadia Investment Management first reported a position in IDXX in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.29M in Q3 2024. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Arcadia Investment Management held 18 shares of Idexx Laboratories worth $10.1K as of Q1 2026.
  • Arcadia Investment Management left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of Arcadia Investment Management's portfolio in Q1 2026, its #208 holding.
  • Arcadia Investment Management first reported a position in Idexx Laboratories in Q1 2024 and has held it in 9 quarters since.
  • Arcadia Investment Management's Idexx Laboratories position peaked at $1.29M in Q3 2024.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Arcadia Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.